Seromycin
Developed to alleviate tuberculosis infections to support bacterial clearance.
- Category
- Antibiotics
- Active ingredient
- Cycloserine
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Capsule, hard
- Strengths
- 250mg
Seromycin details
- Condition
- Tuberculosis
- Therapeutic class
- Antibiotic
- Pharmacological class
- Anti-tuberculosis agent
- Contraindications
- hypersensitivity to cycloserine; epilepsy; severe renal impairment
- Minor side effects
- headache; dizziness
- Moderate side effects
- tremor; confusion; vertigo
- Dosage forms
- Capsule, hard
- Administration route
- Oral use
- Patient summary
- Developed to alleviate tuberculosis infections to support bacterial clearance.
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Mylan
- Onset Time
- n/a
- Duration
- n/a
- Storage instructions
- Store in a tightly closed container.
- Drug interactions
- Alcohol; Ethionamide
- Pregnancy and breastfeeding
- Use during pregnancy only if clearly needed.
Precautions and warnings
monitor for neurological and psychiatric effects; supplementation with vitamin B6 recommended
Serious side effects
seizures, requires immediate medical attention; psychosis, requires immediate medical attention
Mechanism of action
Cycloserine inhibits bacterial cell wall synthesis by acting as an analogue of D-alanine.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Seromycin
Seromycin is a treatment containing cycloserine, used in the management of tuberculosis. Manufactured by Mylan, it is provided as a capsule in the 250mg strength. This medication serves as a therapeutic option for patients requiring this specific active ingredient as part of an ongoing care plan.
Seromycin availability in Asia
Seromycin is registered across 14 markets including Japan, the UAE and Singapore, with availability also in Hong Kong, Thailand and Malaysia. Cycloserine is produced in international manufacturing hubs and serves as an option for patients in regions where access to established medicine can be inconsistent. The treatment is best used under the care of a physician who can monitor progress and individual health needs.